Skip to content
OpenCapital
Get started

MoonLake Immunotherapeutics MLTX Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.43B+533%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.59B+180%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$2.06B+1,531%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$1.97B+78.5%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$6.8B+283%

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Enterprise value$1.36B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Computed from the period-end share price: $1.34B.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's market capitalization?
MoonLake Immunotherapeutics (MLTX) reported market capitalization of $1.34B in Q1 2026.
How has MoonLake Immunotherapeutics's market capitalization changed year-over-year?
MoonLake Immunotherapeutics's market capitalization decreased by 45.9% year-over-year, from $2.47B to $1.34B.
What is the long-term trend for MoonLake Immunotherapeutics's market capitalization?
Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's market capitalization has grown at a 26.5% compound annual growth rate (CAGR), from $365.19M to $933.77M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.